Is a 625 mg dose of co‑amoxiclav (amoxicillin/clavulanic acid) appropriate for a 10‑year‑old child?

Can You Give 625 Co-amoxiclav to a 10-Year-Old?

Yes, a 625 mg tablet (500 mg amoxicillin/125 mg clavulanate) three times daily is an appropriate dose for a 10-year-old child, provided the child weighs at least 40 kg and can swallow tablets. However, for most 10-year-olds who weigh less than 40 kg, weight-based liquid suspension dosing is preferred.

Age-Based Dosing for Standard-Strength Co-amoxiclav

For children aged 7–12 years, the recommended dose is 5 mL of 250/62 suspension three times daily, which provides approximately 250 mg of amoxicillin per dose. 1, 2 This age-based algorithm is the standard approach for uncomplicated infections in this age group. 2

The 625 mg tablet formulation (500 mg/125 mg) three times daily is the adult dose and is appropriate for children in the 7–12 year age bracket who can swallow tablets. 3, 4

Weight-Based Considerations

Children weighing 40 kg or more should be dosed as adults using standard adult formulations and dosing regimens. 1, 2 For a typical 10-year-old weighing less than 40 kg, the pediatric suspension remains the preferred formulation. 1

If the child weighs exactly 40 kg or more, the 625 mg tablet three times daily is entirely appropriate. 2, 4 However, most 10-year-olds weigh between 25–35 kg, making the suspension more suitable.

High-Dose Regimens for Resistant Infections

When risk factors for resistant organisms are present—such as recent antibiotic use within 30 days, daycare attendance, age under 2 years, or residence in areas with >10% penicillin-resistant Streptococcus pneumoniae—a high-dose regimen of 90 mg/kg/day of the amoxicillin component divided twice daily is indicated. 1, 2

For a 10-year-old weighing approximately 30 kg with risk factors, this translates to 1,350 mg of amoxicillin twice daily (approximately 13.5 mL of the 600/42.9 mg per 5 mL suspension twice daily). 1, 5 The standard 625 mg tablet three times daily provides only 1,500 mg total daily amoxicillin, which falls short of the 2,700 mg/day target for high-dose therapy in a 30 kg child.

Indication-Specific Dosing

Respiratory Tract Infections

For community-acquired pneumonia in children ≥5 years, the recommended dose is 90 mg/kg/day of the amoxicillin component divided into two doses (maximum 4 g/day). 1, 2 This high-dose regimen ensures adequate coverage against penicillin-resistant S. pneumoniae and β-lactamase-producing Haemophilus influenzae. 1, 2

Acute Otitis Media

For acute otitis media with risk factors (recent antibiotic use, severe presentation, or bilateral disease in younger children), high-dose amoxicillin-clavulanate (90 mg/kg/day amoxicillin + 6.4 mg/kg/day clavulanate) divided twice daily for 10 days is recommended. 2 The 625 mg tablet three times daily does not provide sufficient amoxicillin for this indication in most 10-year-olds.

Acute Bacterial Sinusitis

For children ≥2 years without risk factors, standard-dose amoxicillin-clavulanate (45 mg/kg/day) is appropriate, but children with recent antibiotic use, daycare attendance, or moderate-to-severe illness require the high-dose regimen (80–90 mg/kg/day). 1, 4

Treatment Duration

The typical treatment duration is 7–10 days for most respiratory infections, with 10 days preferred for pneumonia and acute otitis media. 1, 2 Therapy should continue for at least 48–72 hours after complete resolution of symptoms. 1

Clinical improvement should be evident within 48–72 hours; if no improvement or worsening occurs, reevaluation and possible antibiotic escalation are necessary. 1, 2

Common Prescribing Pitfalls

Avoid Underdosing

Using the 625 mg tablet three times daily in a child who requires high-dose therapy (90 mg/kg/day) will result in treatment failure against resistant organisms. 2 For a 30 kg child requiring high-dose therapy, the 625 mg tablet provides only 50 mg/kg/day—well below the target of 90 mg/kg/day.

Verify Suspension Concentration

Always verify the suspension concentration (125/31,250/62, or 600/42.9 mg per 5 mL) before calculating volume to avoid dosing errors. 2 The 600/42.9 mg per 5 mL formulation is specifically designed for high-dose therapy and is not interchangeable with other suspensions. 5

Do Not Use in Children <3 Months

Amoxicillin-clavulanate should not be routinely used in infants younger than 3 months due to limited safety and pharmacokinetic data in this age group. 2 For serious bacterial infections in this population, intravenous regimens (ampicillin + gentamicin or cefotaxime) are preferred. 2

Practical Administration

Co-amoxiclav should be taken at the start of a meal to minimize gastrointestinal intolerance and enhance absorption of clavulanate. 5 The suspension must be shaken well before each use and stored under refrigeration. 5

Common adverse effects include diarrhea (5–13%), nausea, vomiting, and rash. 2, 4 The high-dose 14:1 ratio formulation (90/6.4 mg/kg/day) causes less diarrhea than other amoxicillin-clavulanate preparations while maintaining efficacy. 1, 2

Summary Algorithm

1. Determine the child's weight:

   • If ≥40 kg: Use adult dosing (625 mg tablet three times daily for standard infections). 1, 2
   • If <40 kg: Use weight-based suspension dosing. 1

2. Assess for risk factors requiring high-dose therapy:

   • Recent antibiotic use (past 30 days), daycare attendance, age <2 years, incomplete Hib vaccination, moderate-to-severe illness, or high local resistance. 1, 2
   • If present: Use 90 mg/kg/day divided twice daily (600/42.9 mg per 5 mL suspension). 1, 2, 5
   • If absent: Use standard dosing (45 mg/kg/day or age-based suspension). 1, 2

3. Select the appropriate formulation:

   • For high-dose therapy: 600/42.9 mg per 5 mL suspension twice daily. 1, 5
   • For standard therapy in 7–12 year-olds: 5 mL of 250/62 suspension three times daily or 625 mg tablet three times daily if able to swallow tablets. 3, 2, 4

4. Monitor response:

   • Expect improvement within 48–72 hours. 1, 2
   • If no improvement or worsening: Consider atypical pathogens, obtain imaging, or escalate therapy. 1, 2